Generic Lipitor is being recalled in the United States by Indian drug manufacturer Ranbaxy Laboratories Ltd. The recall is a development that could further damage the company’s image in the world’s largest prescription drug market.
The generic Lipitor drug being recalled is called atorvastatin, notes Reuters. Ranbaxy, who has also faced an earlier ban in the United States, has not specified the reason for the recall.
The drug is responsible for a big drive in the manufacturer’s sales during the first half of the year. The recall of generic Lipitor is also expected to temporarily disrupt supplies in the US market while the company conducts an investigation that will take around two weeks.
The original drug, made by Pfizer, is considered the world’s best-selling drug ever and generated $13 billion in one year for the company during its peak. Bhagwan Singh Chaudhary, a research associate at the brokerage IndiaNivesh, stated:
“The development will impact the company’s credibility to an extent. There have been issues in the past [about compliance] and a recall suggests, corrective measures suggested by the U.S. FDA are not being implemented.”
The Los Angeles Times notes that Ranbaxy is recalling 10-, 20-, and 40-milligram doses of the generic Lipitor drug atorvastatin. The recall includes 41 different lots of the drug, most of which come with 90 pills per bottle. Three of the lots, however, contain 500 pills per bottle.
A spokesman for Ranbaxy did not respond to comment, but the company posted a notice on their website, saying:
“Ranbaxy is proactively recalling the drug product lots out of an abundance of caution. This recall is being conducted with the full knowledge of the U.S. FDA.”
Customers who are taking generic Lipitor and are interested about the recall can call their pharmacy to see if the pills are made by Ranbaxy. If they are, the pharmacist can tell them if they need to return the medication.